Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Eosinophils play an important role in the pathogenesis of asthma and can be activated by extracellular nucleotides released following cell damage or inflammation. For example, increased ATP concentrations were reported in bronchoalveolar lavage fluids of asthmatic patients. Although eosinophils are...

書誌詳細
主要な著者:	Wright, A, Mahaut-Smith, M, Symon, F, Sylvius, N, Ran, S, Bafadhel, M, Muessel, M, Bradding, P, Wardlaw, A, Vial, C
フォーマット:	Journal article
言語:	English
出版事項:	American Association of Immunologists 2016

類似資料

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
著者:: Brightling, C, 等
出版事項: (2003)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
著者:: Brightling, C, 等
出版事項: (2002)

Mepolizumab in refractory eosinophilic asthma.
著者:: Pavord, I, 等
出版事項: (2010)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
著者:: Mistry Vijay, 等
出版事項: (2009-07-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
著者:: Shrimanker, R, 等
出版事項: (2017)

Eotaxin and the attraction of eosinophils to the asthmatic lung
著者:: Williams Timothy J, 等
出版事項: (2001-03-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
著者:: Shrimanker, R, 等
出版事項: (2017)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
著者:: Berry, M, 等
出版事項: (2007)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
著者:: Eltboli, O, 等
出版事項: (2014)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
著者:: Chen Zhan, 等
出版事項: (2022-03-01)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients
著者:: Ilknur Basyigit, 等
出版事項: (2004-01-01)

IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.
著者:: Morgan, A, 等
出版事項: (2005)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
著者:: Hambleton, K, 等
出版事項: (2017)

Evaluation Role of IL-13 and Eosinophils in Adult Asthmatic Patients
著者:: Meraim A. Kazaal, 等
出版事項: (2023-06-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
著者:: Haldar, P, 等
出版事項: (2009)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
著者:: Bradding Peter
出版事項: (2008-06-01)

Serum cytokines and treatment response in atopic and non-atopic eosinophilic asthmatics
著者:: Jamille Fernandes, 等
出版事項: (2020-08-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
著者:: Green, R, 等
出版事項: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
著者:: Berry, M, 等
出版事項: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
著者:: Siddiqui, S, 等
出版事項: (2007)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
著者:: Haldar, P, 等
出版事項: (2014)

The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects
著者:: J. Grzegorczyk, 等
出版事項: (2000-01-01)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
著者:: Woltmann, G, 等
出版事項: (1999)

Eosinophils in COPD: just another biomarker?
著者:: Bafadhel, M, 等
出版事項: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
著者:: Russell, R, 等
出版事項: (2018)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
著者:: Brightling, C, 等
出版事項: (2003)

Mast-cell infiltration of airway smooth muscle in asthma.
著者:: Brightling, C, 等
出版事項: (2002)

Characterising non-eosinophilic COPD
著者:: Hambleton, K, 等
出版事項: (2015)

Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients
著者:: Maged Mohamed Refaat, 等
出版事項: (2022-10-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
著者:: Bilocca, D, 等
出版事項: (2017)

Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
著者:: Sophie F. Demarche, 等
出版事項: (2017-07-01)

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
著者:: Mahajan, L, 等
出版事項: (2008)

Role of Adhesion Molecules in Eosinophil Activation: A Comparative Study on the Effect of Adhesion Molecules on Eosinophil Survival
著者:: Kazutoshi Yamaguchi, 等
出版事項: (2004-01-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
著者:: Lababidi, R, 等
出版事項: (2017)

Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults
著者:: Jun Wen, 等
出版事項: (2024-05-01)

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
著者:: Patrizia Pignatti, 等
出版事項: (2019-07-01)

Relationship between triglyceride-glucose index and blood eosinophils among asthmatic individuals in the USA
著者:: Jun Wen, 等
出版事項: (2024-05-01)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
著者:: Saunders, R, 等
出版事項: (2017)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
著者:: Saunders, R, 等
出版事項: (2017)

The significance of eosinophilic airway inflammation in asthma
著者:: Pavord, I, 等
出版事項: (2002)